BioStable Science & Engineering Announces announced today the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia. Dr. Lawrence Wei, Dr. Vinay Badhwar and Dr. J. Scott Rankin, were the collaborating surgeons for the procedures.
BioStable Science & Engineering will be at the 100th Anniversary of the American Association for Thoracic Surgery - AATS Centennial - from April 29 - May 3, 2017 in Boston, MA - booth 834.
BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device designed for aortic valve repair.
BioStable Science & Engineering will be at the 46th Annual Meeting of the German Society for Thoracic, Cardiac and Vascular Surgery - Heart Medicine 2017 from February 11 - 14, 2017 in Leipzig, Germany - booth C.11.
BioStable Science & Engineering will be at the 53rd STS Annual Meeting of the Society of Thoracic Surgeons from January 21 – 25, 2017 in Houston, TX at booth 819.